158 related articles for article (PubMed ID: 25676864)
1. Vitamin D3 analogues that contain modified A- and seco-B-rings as hedgehog pathway inhibitors.
DeBerardinis AM; Raccuia DS; Thompson EN; Maschinot CA; Kyle Hadden M
Eur J Med Chem; 2015 Mar; 93():156-71. PubMed ID: 25676864
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of hybrid vitamin D3 side chain analogues as hedgehog pathway inhibitors.
Banerjee U; DeBerardinis AM; Hadden MK
Bioorg Med Chem; 2015 Feb; 23(3):548-55. PubMed ID: 25549899
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
Maschinot CA; Chau LQ; Wechsler-Reya RJ; Hadden MK
Eur J Med Chem; 2019 Jan; 162():495-506. PubMed ID: 30471551
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for vitamin D3-based aromatic a-ring analogues as hedgehog pathway inhibitors.
Deberardinis AM; Madden DJ; Banerjee U; Sail V; Raccuia DS; De Carlo D; Lemieux SM; Meares A; Hadden MK
J Med Chem; 2014 May; 57(9):3724-36. PubMed ID: 24730984
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of vitamin D3 A-ring analogues as Hedgehog pathway inhibitors.
Banerjee U; Ghosh M; Kyle Hadden M
Bioorg Med Chem Lett; 2012 Feb; 22(3):1330-4. PubMed ID: 22226657
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of vitamin D3 analogues with C-11 modifications as inhibitors of Hedgehog signaling.
Maschinot CA; Hadden MK
Bioorg Med Chem Lett; 2017 Sep; 27(17):4011-4014. PubMed ID: 28780161
[TBL] [Abstract][Full Text] [Related]
7. Affinity-based protein profiling identifies vitamin D3 as a heat shock protein 70 antagonist that regulates hedgehog transduction in murine basal cell carcinoma.
Wen J; Hadden MK
Eur J Med Chem; 2022 Jan; 228():114005. PubMed ID: 34844141
[TBL] [Abstract][Full Text] [Related]
8. Structure-Activity Relationship Studies of Vitamin D3 Analogues Containing an Ether or Thioether Linker as Hedgehog Pathway Inhibitors.
Wen J; Hadden MK
ChemMedChem; 2018 Apr; 13(7):748-753. PubMed ID: 29409113
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of optimized phthalazine derivatives as hedgehog signaling pathway inhibitors.
Lu X; Peng Y; Wang C; Yang J; Bao X; Dong Q; Zhao W; Tan W; Dong X
Eur J Med Chem; 2017 Sep; 138():384-395. PubMed ID: 28688278
[TBL] [Abstract][Full Text] [Related]
10. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
11. Identification of vitamin d3-based hedgehog pathway inhibitors that incorporate an aromatic a-ring isostere.
DeBerardinis AM; Banerjee U; Hadden MK
ACS Med Chem Lett; 2013 Jul; 4(7):590-5. PubMed ID: 24900716
[TBL] [Abstract][Full Text] [Related]
12. Probing the structural requirements for vitamin D3 inhibition of the hedgehog signaling pathway.
DeBerardinis AM; Banerjee U; Miller M; Lemieux S; Hadden MK
Bioorg Med Chem Lett; 2012 Jul; 22(14):4859-63. PubMed ID: 22687748
[TBL] [Abstract][Full Text] [Related]
13. Probing seco-steroid inhibition of the hedgehog signaling pathway.
Thompson EN; Sail V; Raccuia DS; Hadden MK
Mol Cell Biochem; 2019 Jan; 450(1-2):75-85. PubMed ID: 29876765
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel dimethylpyridazine derivatives as hedgehog signaling pathway inhibitors.
Wang C; Zhu M; Lu X; Wang H; Zhao W; Zhang X; Dong X
Bioorg Med Chem; 2018 Jul; 26(12):3308-3320. PubMed ID: 29739714
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies.
Banerjee U; Hadden MK
Expert Opin Drug Discov; 2014 Jul; 9(7):751-71. PubMed ID: 24850423
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications.
Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
J Med Chem; 2009 Oct; 52(19):6158-62. PubMed ID: 19739672
[TBL] [Abstract][Full Text] [Related]
17. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway.
O'Kelly J; Uskokovic M; Lemp N; Vadgama J; Koeffler HP
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):107-16. PubMed ID: 16777406
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of structurally modified isoindolinone and quinazolinone derivatives as hedgehog pathway inhibitors.
Bhattarai D; Jung JH; Han S; Lee H; Oh SJ; Ko HW; Lee K
Eur J Med Chem; 2017 Jan; 125():1036-1050. PubMed ID: 27810591
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors.
Pace JR; Teske KA; Chau LQ; Dash RC; Zaino AM; Wechsler-Reya RJ; Hadden MK
J Med Chem; 2019 Apr; 62(8):3873-3885. PubMed ID: 30896941
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel vitamin D3 analog with an additional ring annulated to A and seco-B rings.
Sokolowska K; Sicinski RR
Steroids; 2014 Sep; 87():67-75. PubMed ID: 24928728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
